Issue 4 of SF Pulse is out now! The newest issue dives into five topics including: A deep dive into how Johnson & Johnson starts thinking about anti-counterfeiting needs well before the product launch. An article by the Global Initiative Against Transnational Organized Crime highlighting the risks that an increased Read more…
On October 3rd, FTFA was invited by the World Trade Organization to speak at a closed-door panel discussion about “Substandard, Falsified and Counterfeit Medical Products” alongside the World Health Organization and the World Customs Organization. The event brought together country representatives from 30+ countries in the context of WTO’s annual Read more…
The Global Pharma Health Fund (GPHF), a non-profit organization supported by Merck KGaA, is pleased to announce the Special Edition 2024, featuring a new Minilab test for detecting the toxic antifreeze agents diethylene glycol (DEG) and ethylene glycol (EG). The GPHF-Minilab is a portable mini-laboratory designed to detect substandard, falsified, and adulterated medicines, especially Read more…
September 24, 2024, Location – Fight the Fakes Alliance is excited to announce and welcome the Université la Source Conakry as the newest member of the Alliance. Given that one-fifth of medicines in Africa are potentially substandard or falsified (SFs), and that SFs in sub-Saharan kill almost 500,000 people each Read more…
Medical Product Alert N°3/2024: Falsified (contaminated) Oxymorphone Hydrochloride 40mg Alert Summary This WHO Medical Product Alert refers to one batch of falsified Oxymorphone Hydrochloride 40mg. The falsified product was detected in the unregulated supply chain in Finland and reported to WHO in July 2024 by the Finnish Medicines Agency (FIMEA). Read more…
On July 31st, 24, BBC published an article on the devastating effects surrounding the online purchases of fake semaglutide – an active ingredient in legal drugs like Ozempic, a type 2 diabetes drug, and Wegovy, a weight loss drug. The article interviewed a member of Fight the Fakes Alliance, Oksana Read more…
Our third SF Pulse Issue is out! SF Pulse is a bi-monthly newsletter that aims to elevate important issues and relevant stories shaping the ongoing fight against substandard and falsified medical products (SFs). The newest issue includes 7 important updates across many topics including: A blog post from a financial Read more…
This report highlights the urgent need for enhanced education, collaboration, and country-based initiatives to curb the growing global crisis. Geneva, Switzerland July 29th, 2024 – Fight the Fakes Alliance (FTFA) has released its white paper on Identifying Critical Enablers in the Prevention, Detection, and Response to Substandard and Falsified Medicines . Read more…
On Friday, 26th July, the FDA, FTFA member USP, and the Asia Pacific Economic Cooperation (APEC) announced the launch of the new web-based version of APEC’s Supply Chain Security (SCS) Toolkit, an essential resource designed to enhance the quality and security of medical products across the global supply chain. Securing Read more…
On July 12, 2024, the New York Times published an article on the rise of counterfeit Ozempic and highlighting the greater risk of buying drugs online. The article interviewed a member of Fight the Fake Alliance, Shabbir Imber Safdar, Executive Director of the Partnership for Safe Medicines. You can access Read more…